Cargando…
Patient-driven N-of-1 in Parkinson’s Disease: Lessons Learned from a Placebo-controlled Study of the Effect of Nicotine on Dyskinesia
Background: New insights and knowledge in biomedical science often come from observation and experimentation. Methods traditionally used include self-experimentation, case reports, randomised controlled trials, and N-of-1 studies. Technological advances have lead to an increasing number of individua...
Autores principales: | Riggare, Sara, Unruh, Kenton T., Sturr, Jasmine, Domingos, Josefa, Stamford, Jonathan A., Svenningsson, Per, Hägglund, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Schattauer GmbH
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291823/ https://www.ncbi.nlm.nih.gov/pubmed/29064509 http://dx.doi.org/10.3414/ME16-02-0040 |
Ejemplares similares
-
A Long Way to Go: Patient Perspectives on Digital Health for Parkinson’s Disease
por: Riggare, Sara, et al.
Publicado: (2021) -
Patients are doing it for themselves: A survey on disease-specific knowledge acquisition among people with Parkinson’s disease in Sweden
por: Riggare, Sara, et al.
Publicado: (2017) -
Precision Medicine in Parkinson’s Disease – Exploring Patient-Initiated Self-Tracking
por: Riggare, Sara, et al.
Publicado: (2018) -
Paroxysmal Kinesigenic Dyskinesia
por: Paucar, Martin, et al.
Publicado: (2017) -
Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
por: Svenningsson, Per, et al.
Publicado: (2018)